Top global biotech companies based on market capitalization 2019
This statistic depicts the global top 10 biotechnology companies based on market capitalization as of October 30, 2019. At this point, Danish biopharmaceutical manufacturer Novo Nordisk was ranked third among such companies, with a market capitalization of around 104 billion U.S. dollars.
Global biotechnology
Gilead Sciences and Novo Nordisk are among the largest biotechnology companies in the world. In October 2019, Gilead Sciences, a company based in the U.S., had a market capitalization of 80 billion U.S. dollars, while Novo Nordisk had market capitalization of nearly 104 billion U.S. dollars. As of 2017, there were 832 companies in the United States dedicated to biotechnology developments, and in comparison, Germany had 646 companies. Biotech companies located in the San Francisco Area and in Los Angeles/Orange County generate the highest amount of biotech revenue within the United States.
In the United States, developments for medical biotechnology are a significant component of the biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated some 19.9 billion U.S. dollars in revenue globally in 2018. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 89.1 million acres of corn crops in the United States, only 7.1 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.
Global biotechnology
Gilead Sciences and Novo Nordisk are among the largest biotechnology companies in the world. In October 2019, Gilead Sciences, a company based in the U.S., had a market capitalization of 80 billion U.S. dollars, while Novo Nordisk had market capitalization of nearly 104 billion U.S. dollars. As of 2017, there were 832 companies in the United States dedicated to biotechnology developments, and in comparison, Germany had 646 companies. Biotech companies located in the San Francisco Area and in Los Angeles/Orange County generate the highest amount of biotech revenue within the United States.
In the United States, developments for medical biotechnology are a significant component of the biotech industry. Jobs in research, testing, and medical laboratories have increased significantly. Humira, an anti-inflamatory drug, was developed by AbbVie and has generated some 19.9 billion U.S. dollars in revenue globally in 2018. The biopharmaceutical market is expected to continue to grow due to new innovations and the demand for quality medical technologies. Biotechnology is also commonly used in agriculture. Biotech crops in the United States accounts for more than half of the world’s total. With a total of 89.1 million acres of corn crops in the United States, only 7.1 million acres are considered non-biotech fields. Biotechnology also extends into the industrial sector, providing innovation for nanotechnology, enzymes, and biofuels.
